Supreme Court Position on Obamacare Birth Control Mandate a Tough Call

Washington Times, December 25, 2013
Tom Howell, Jr., quoting Holly Fernandez Lynch

[...] "It also probably will not matter that three of the court’s justices - Ruth Bader Ginsburg, Sonia Sotomayor and Elena Kagan - are female, even if the case involves the coverage of contraceptive services that are used by women, said Holly Lynch, a health…

Read More

Defining mental illnesses: can values and objectivity get along?

BMC Psychiatry 13:346, December 24, 2013
Dominic Sisti, Michael Young (PFC Student Fellow), and Arthur Caplan

Abstract Background The creation of each edition of the Diagnostic and Statistical Manual (DSM) of psychiatry has proven enormously controversial. The current effort to revise the ‘bible’ of disorder definitions for the field of mental health is no exception. The controversy…

Read More

Past sperm and egg donors split on losing anonymity

Reuters, December 21, 2013
Shereen Jegtvig, quoting I. Glenn Cohen

[...] The ethical considerations of egg and sperm donor anonymity are complicated, researchers said. "Those in favor of non-anonymity or mandatory identification rules tend to argue from the perspective of the rights of the child that's born and talk about the right to know your genetic…

Read More

These Two Americans Want Babies Through Indian Surrogates.: It's Not Been Easy.

The New Republic, December 10, 2013
Jennifer Kirby, citing I. Glenn Cohen

[...] An estimated 2,000 foreign babies are born to Indian surrogates each year, according to research in the forthcoming book Patients With Passports: Medical Tourism, Ethics, and Law, by Harvard law professor I.…

Read More

Harvard Law School to Host Conference on Food Safety Law

Food Safety News, December 10, 2013
James Andrews

The Petrie-Flom Center's upcoming conference "New Directions for Food Safety: The Food Safety Modernization Act and Beyond," which will be held at Harvard Law School on Friday, February 21, 2014, was…

Read More

Do Fixed Patent Terms Distort Innovation?: Evidence from Cancer Clinical Trials

Public Health Law & Policy e-Journal 5, no. 64, December 4, 2013
Eric B. Budish, Benjamin N. Roin, and Heidi Williams

Abstract: Patents award innovators a fixed period of market exclusivity, e.g., 20 years in the United States. Yet, since in many industries firms file patents at the time of discovery ("invention") rather than first sale ("commercialization"), effective patent terms vary: inventions…

Read More

Petrie-Flom Center to collaborate with Harvard Catalyst: on second Clinical and Translational Science Award

Official Press Release:  Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics will launch a novel Ethics and Law initiative as part of the Regulatory Foundations, Ethics, and Law Program of Harvard…

Read More

The Jurisdiction of the D.C. Circuit

Cornell Journal of Law and Public Policy, Vol. 23, No. 1, 2013
Eric M. Fraser, David K. Kessler, Matthew J.B. Lawrence, and Stephen Calhoun

Abstract: The U.S. Court of Appeals for the D.C. Circuit is unique among federal courts. It is well known for its unusual caseload, which is disproportionally weighted toward administrative law. What explains the unusual caseload? This Article explores the inputs into the D.C.…

Read More

Now Available: Bioethical Prescriptions: To Create, End, Choose, and Improve Lives

Oxford University Press, 2013
Frances Kamm

Bioethical Prescriptions collects Frances M. Kamm's articles on bioethics, which…

Read More

Announcing the New Journal of Law and the Biosciences

Oxford University Press, Forthcoming 2014
Petrie-Flom Center and HLS, Duke University, and Stanford University

The Petrie-Flom Center and Harvard Law School are delighted to announce our partnership with Duke University, Stanford University, and Oxford University Press to launch a new peer-reviewed, open access, online journal in 2014: Journal…

Read More

Supreme Court to decide Obamacare birth control mandate

Washington Times, November 26, 2013
Tom Howell Jr., quoting Holly Fernandez Lynch

[...] Ms. Lynch said the outcome is a particularly hard one to predict. But she thinks the court will dispense with the constitutional claims and focus more heavily on religious-freedom protection in RFRA. …

Read More

VIDEO NOW AVAILABLE: Stem Cell Therapies:: Opportunities for Assuring the Quality and Safety of Unregulated Clinical Offerings

Institute of Medicine, November 18, 2013
Co-organized by I. Glenn Cohen

Stem cells hold tremendous potential to advance health and medicine. Through replacement of damaged cells and organs or supporting intrinsic repair, stem cell offer promising treatments for debilitating diseases and conditions such as Parkinson’s disease, diabetes, and spinal cord injury. Currently,…

Read More

Have Injury, Will Travel:: With medical costs exploding, young adventurers are opting to go under the knife overseas. Is the risk worth it?

Outside Magazine, November 14, 2013
Emily Matchar, quoting I. Glenn Cohen

[...] Most people who travel abroad for medical care are uninsured or underinsured, with high-copay or high-deductible insurance, says Glenn Cohen, a professor atHarvard Law School who studies medical tourism. [...]

Read More

Genes without Patents: ACLU attorney joins discussion of Supreme Court case

Harvard Gazette, November 14, 2013
Alvin Powell, featuring I. Glenn Cohen

As Supreme Court Justice Elena Kagan questioned Myriad Genetics’ attorney about patenting genes, Chris Hansen rejoiced. The attorney said that yes, genes should be patentable. But it was only under the pressure of further questions that he said that chromosomes, too, should be patentable,…

Read More

Chris Hansen on “Dis-Owning Nature: The BRCA Gene Patents and the Supreme Court”

Program on Science, Technology, & Society at HKS, November 12, 2013
Featuring I. Glenn Cohen as a discussant

ABOUT THE SPEAKER Chris Hansen joined the ACLU in 1973. He spent 10 years at the NYCLU specializing in complex litigation seeking reform of the mental retardation and mental health systems. He then spent 10 years as the Associate Director of the Children’s Rights Project of the ACLU specializing…

Read More

Peter Singer Advocates for Animal Rights

The Harvard Crimson, November 10, 2013
Joanna R. Schacter

[...] Friday’s talk was part of a series sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at the Law School. Singer also spoke later in the day in the Science Center about effective altruism—a utilitarian stance on how best to affect change in the…

Read More

Class in Session: Health Law Professors Share Career Insight and Experience: featuring Petrie-Flom faculty co-director I. Glenn Cohen

Boston Bar Association, October 29, 2013

Local professors specializing in health care law will discuss their career paths and offer highlights of their current research endeavors. Current practitioners and law students will learn about different paths into academia and gain a better understanding of the types of research being conducted…

Read More

Informed consent for return of incidental findings in genomic research

Genetics in Medicine, October 24, 2013
Paul S. Appelbaum, Cameron R. Waldman, Abby Fyer, Robert Klitzman, Erik Parens, Josue Martinez, W. Nicholson Price II, & Wendy K. Chung

Purpose: Researchers face the dilemma of how to obtain consent for return of incidental findings from genomic research. We surveyed and interviewed investigators and study participants, with the goal of providing suggestions for how to shape the consent process. Methods: We…

Read More

Pharma manufacturing woes dog industry

Chemistry World, October 23, 2013
Sarah Moulton, quoting W. Nicholson Price II

[...] While many of these problems arise from quality control failures, according to Nicholson Price from Harvard Law School’s Petrie-Flom centre for health law policy, biotechnology and bioethics, this is not the only problem – regulatory constraints can prevent process improvements…

Read More

Plan B: access to emergency contraception in the legal and political cross hairs

Association of Reproductive Health Professionals, Contraception Journal, October 2013
I. Glenn Cohen, Lisa Sullivan, Eli Y. Adashi

The 8-year legal feud over access to emergency contraception between reproductive health advocates and the Food and Drug Administration (FDA) took multiple unexpected turns before coming to an abrupt end on June 10, 2013.1,2,3 On that day, after mounting legal setbacks and obstacles, the US Attorney…

Read More